BioHarvest Sciences Inc. Announces Live Quarterly Shareholder Update Event July 7, 2022, at 2:00 PM ET
British Columbia and Rehovot, Israel--(Newsfile Corp. - June 24, 2022) - BioHarvest Sciences Inc. (CSE: BHSC) ("BioHarvest" or "the Company") invites its shareholders and the general public to join a Live Video Conference ("Webinar") on Thursday, July 7, 2022, at 2:00 PM Eastern Standard Time (11:00 AM Pacific Standard Time). BioHarvest Sciences CEO Ilan Sobel will host the event, which will include coverage of Q2 sales results and a detailed progress update on the 2022 Growth Priorities,...
2022-06-24 9:00 AM EDT
BioHarvest Sciences Hires Dr. Brian S. Cornblatt as Chief Medical Officer
Rehovot, Israel--(Newsfile Corp. - May 31, 2022) - BioHarvest Sciences Inc. (CSE: BHSC) ("BioHarvest" or the "Company") has hired Dr. Brian S. Cornblatt as its Chief Medical Officer, marking a significant milestone in the Company's route for the development of next generation therapeutic solutions including botanical drugs. Dr. Cornblatt has served as Director of Consumer Clinical Research and Science and as Medical Director at Nutramax Laboratories Consumer Care, Inc. In this role Dr....
2022-05-31 7:30 AM EDT
BioHarvest Sciences Unveils Profile of Unique Cannabis Composition
Rehovot, Israel--(Newsfile Corp. - May 12, 2022) - BioHarvest Sciences Inc. the (CSE: BHSC) ("BioHarvest" or the "company") today unveiled the composition profile of its full-spectrum Cannabis produced in large-scale industrial bioreactors based on its proprietary Bio-Plant CELLicitation™ platform technology. On December 8th, 2021, BHSC b
2022-05-12 7:00 AM EDT
BioHarvest Sciences Inc. Announces a Private Placement of up to USD $5 Million of Convertible Notes to Finance Production Facilities and Scaling of Core Business
British Columbia and Rehovot, Israel--(Newsfile Corp. - April 7, 2022) - BioHarvest Sciences Inc. (CSE: BHSC) (OTC:CNVCF) (FSE: 8MV) ("BioHarvest" or the "Company") announced today a financing plan based on a private placement of up to USD $5 Million (approximately $6.3 Million CAD). The funds raised will allow the Company to accelerate the growth plan for its polyphenols/antioxidants and Cannabis verticals. On March 23, 2021, BHSC announced the completion of the Company's Cannabis R&D...
2022-04-07 7:30 AM EDT
Bioharvest Sciences Inc. Reports Strong Q1 2022 Results on All of the Company's Activities
British Columbia and Rehovot, Israel--(Newsfile Corp. - April 6, 2022) - BioHarvest Sciences Inc. (CSE: BHSC) (OTC PINK: CNVCF) (FSE:8MV) ("BioHarvest" or "the Company") today announced Q1 202
2022-04-06 7:30 AM EDT
Bioharvest Sciences Inc. Successfully Completes Cannabis R&D Program
British Columbia and Rehovot, Israel--(Newsfile Corp. - March 23, 2022) - BioHarvest Sciences Inc. (CSE: BHSC) ("BioHarvest" or the "Company") today announced that it has produced Cannabis Biomass in large scale industrial bioreactors, which represents the completion of the Company's Cannabis R&D program. On December 8th, 2021, BHSC became the first company ever to announce that it could produce Cannabis biomass without growing the plant itself. Building on that breakthro
2022-03-23 7:00 AM EDT
BioHarvest Sciences Inc. Quarterly Shareholder Update Live Event April 7, 2022, at 2:00 PM E.T.
Rehovot, Israel--(Newsfile Corp. - March 11, 2022) - BioHarvest Sciences Inc. (CSE: BHSC) ("BioHarvest" or "the Company") invites its shareholders and the general public to join a Live Video Conference ("Webinar") on Thursday, April 7, 2022, at 2:00 PM Eastern Standard Time (11:00 AM Pacific Standard Time). BioHarvest Sciences CEO Ilan Sobel will host the event, which will include an unveiling of the 2022 Growth Priorities, including a detailed performance update on the commercialization of...
2022-03-11 7:00 AM EST
BioHarvest Sciences Inc. Trademarks Its Breakthrough Non-GMO Proven Platform Technology: "BIO-PLANT CELLicitation"
British Columbia and Rehovot, Israel--(Newsfile Corp. - February 16, 2022) - BioHarvest Sciences Inc. (CSE: BHSC) ("BioHarvest" or "the Company") has announced the new trademark for its proprietary non-GMO Biotech platform technology. The new name, "Bio-Plant CELLicitation™," replaces "BioFarming" and underscores the potential for the technology to be used in the botanical drugs space. "The Bio-Plant CELLicitation™ proven platform technology allows us to address multiple market verticals with...
2022-02-16 5:55 AM EST
BioHarvest Sciences Inc. Engages Thunder11 as a Public Relations Agency of Record
British Columbia and Rehovot, Israel--(Newsfile Corp. - February 10, 2022) - BioHarvest Sciences Inc. (CSE: BHSC) (OTC PINK: CNVCF) (FSE:8MV) ("BioHarvest" or "the Company") a fast-growing Biotech firm listed on the Canadian Securities Exchange, has engaged the award winning New York City-based communications firm Thunder11 for Public Relations services. Thunder11, which has specializations in technology, healthcare, and public affairs, will be involved in raising BioHarvest's profile with...
2022-02-10 5:55 AM EST
BioHarvest Sciences Inc. to Present at BIO CEO & Investor Conference in New York City on February 14-17, 2022
Rehovot, Israel--(Newsfile Corp. - February 3, 2022) - BioHarvest Sciences Inc. (CSE: BHSC) ("BioHarvest" or "the Company") is pleased to announce that it has been selected as a presenter at the upcoming BIO CEO & Investor Conference, hosted by the Biotechnology Innovation Organization in New York City on Feb 14-17. CEO Ilan Sobel will deliver a virtual presentation and will conduct investor meetings and industry networking by remote at the event, which this year will be "hybrid" and will...
2022-02-03 5:55 AM EST
BioHarvest Sciences Inc. Projects 2022 Revenue to Grow 2.5X-3.5X to a Range of USD $5M-$7M
Rehovot, Israel--(Newsfile Corp. - January 26, 2022) - BioHarvest Sciences Inc. (CSE: BHSC) ("BioHarvest" or "the Company") announces that following the successful over-delivery of revenue targets versus guidance provided in 2021, the Company is estimating 2022 revenue to be between USD $5M-$7M, representing a significant growth of 2.5X-3.5X over 2021. The range
2022-01-26 5:55 AM EST
BioHarvest Sciences Inc. Plans to Build a Production Facility in Ontario to Serve the Canadian Market with Unique Cannabis Products
Rehovot, Israel--(Newsfile Corp. - January 20, 2022) - BioHarvest Sciences Inc. (CSE: BHSC) ("BioHarvest" or the "Company") has announced its plan to build a production facility in Canada, as part of the next phase in the global expansion of its Cannabis vertical. To that end, the Company is exploring opportunities to acquire an existing licensed facility or a Licensed Producer (LP), which would enable the Company to use its BioFarming technology to produce and then sell unique cannabis...
2022-01-20 5:55 AM EST
BioHarvest Sciences Reports Double-Digit Q4 Sales Orders Growth in First Full Year of VINIA Sales
Rehovot, Israel--(Newsfile Corp. - January 6, 2022) - BioHarvest Sciences Inc. (CSE: BHSC) ("BioHarvest" or the "Company") today announces another strong quarter of sales growth for VINIA®, its nutrient-rich red grape supplement created through the Company's proprietary BioFarming technology, in both Israel and the United States. The USD 825k of sales orders in
2022-01-06 6:55 AM EST
BioHarvest Sciences Inc. 2021 CEO Letter to Shareholder Partners
British Columbia and Rehovot, Israel--(Newsfile Corp. - December 30, 2021) - BioHarvest Sciences Inc. (CSE: BHSC) (OTC PINK: CNVCF) ("BioHarvest" or the "Company") is pleased to provide the following year-end shareholder partner letter from CEO Ilan Sobel. Dear friends, It is with great pleasure that I take this opportunity at the end of the year to summarize for our shareholder partners the major accomplishments of what has been an inspiring and transformative first full calendar year for me...
2021-12-30 8:55 AM EST
BioHarvest Sciences Inc. Produces Significant Amount of Cannabis Without Growing the Cannabis Plant
British Columbia and Rehovot, Israel--(Newsfile Corp. - December 8, 2021) - BioHarvest Sciences Inc. (CSE: BHSC) ("BioHarvest" or the "Company") has announced that it has produced a meaningful amount (10 kilograms) of full-spectrum Cannabis biomass at a commercial scale without growing the plant itself. (For full illustration, watch the "
2021-12-08 7:19 AM EST
BioHarvest Sciences New 20 Tons per Year Factory Obtains the GMP (Good Manufacturing Practices) Certification from the Israeli Ministry of Health
British Columbia and Rehovot, Israel--(Newsfile Corp. - November 22, 2021) - BioHarvest Sciences Inc. (CSE: BHSC) ("BioHarvest" or the "Company") announces that the new manufacturing facility in Israel has obtained the GMP (Good Manufacturing Practices) certification from the Israeli Ministry of Health. The GMP certificate is pursuant to the successful fulfillment of the Israeli Ministry of Health's ISO9001 and ISO22000 (HACCP)
2021-11-22 8:35 AM EST
New Research Analysis Shows VINIA Reduces Oxidation Of LDL-Cholesterol To Support Cardiovascular Improved Functioning
British Columbia and Rehovot, Israel--(Newsfile Corp. - November 15, 2021) - BioHarvest Sciences Inc. (CSE: BHSC) ("BioHarvest" or the "Company") reports that recent research analysis provides additional support for anti-oxidation structure/function claims of VINIA®. This analysis, when added
2021-11-15 8:35 AM EST
BioHarvest Sciences Inc. Appoints Steven Lehrer to Its Board of Advisors
Rehovot, Israel--(Newsfile Corp. - October 27, 2021) - BioHarvest Sciences Inc. (CSE: BHSC) ("BioHarvest" or the "Company") announces that effective immediately, Steven Lehrer will be serving on its board of advisors. Complementing an already competent list of advisors that includes a significant array of expertise, Steven brings 40 years of expe
2021-10-27 8:35 AM EDT
BioHarvest Sciences Inc. Announces Appointment of David Tsur to Board of Directors
British Columbia and Rehovot, Israel--(Newsfile Corp. - October 21, 2021) - BioHarvest Sciences Inc. (CSE: BHSC) (FSE: 8MV) ("BioHarvest" or the "Company") today announced that David Tsur has agreed to serve as a non-executive director of BioHarvest. The appointment is effective immediately.
2021-10-21 8:55 AM EDT
BioHarvest Sciences Inc. Increases Its VINIA 2021 Annual Sales Orders Forecast for Israel by 15%
Rehovot, Israel--(Newsfile Corp. - October 13, 2021) - BioHarvest Sciences Inc. (CSE: BHSC) (FSE: 8MV) ("BioHarvest" or the "Company") today announces an update to its forecast of 2021 annual sales orders for VINIA® in Israel. The Company has increased its 2021 sales orders forecast for Israel to US$ 1.6M - US$ 1.7M from the previous forecast of US$ 1.3M - US$ 1.5M announced in March 2021. The continued adoption of VINIA® in Israel demonstrates the health benefits and efficacy of the product....
2021-10-13 8:55 AM EDT